"Leica" Bond Ready-to-Use Primary Antibody S-100 (Polyclonal)(Non-Sterile) - Taiwan Registration 0323168158e1a3c02e1a26e3b06576ba

Access comprehensive regulatory information for "Leica" Bond Ready-to-Use Primary Antibody S-100 (Polyclonal)(Non-Sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 0323168158e1a3c02e1a26e3b06576ba and manufactured by LEICA BIOSYSTEMS NEWCASTLE LTD.. The authorized representative in Taiwan is BECKMAN COULTER TAIWAN INC., TAIWAN BRANCH (U.S.A.).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.